InsidersTradesSigma
Explore the complete record of transactions filed by 김태군, Directeur Exécutif (CTO). Insider active across 2 companies, notably 리메드. In total, 1 reports have been published. The latest transaction was disclosed on 9 April 2026 — Purchase. Regulator: DART (FSS). All data is openly available.
1 of 1 declaration
Kim Tae-gun serves as the Chief Technology Officer at Remed, an innovative company in the medical technology field. He is responsible for leading technological initiatives and research and development within the company. With deep expertise in his field, Kim Tae-gun plays a key role in developing innovative solutions that meet market needs. His technical leadership is essential for maintaining Remed's competitiveness.